In this role, Foster will help Aphena to shape its vision, plan long-term goals, and further enhance the company's rigorous adherence to the highest quality and regulatory standards.
A senior-level regulatory/quality professional with more than 25 years of experience, Foster comes to Aphena from Catalent Pharma Solutions, where she served as vice president of quality. In that role, she was responsible for creating a global current Good Manufacturing Practices (cGMP) program and for training and developing connections within the industry and worldwide regulatory bodies to ensure continuous understanding and improvement of quality processes.
"We're so pleased to have Mary join the company. It is our intent to employ the industry's best and brightest, Mary certainly fits that category" said Aphena President and CEO Renard Jackson. "She shares our company's values, our focus on client expectations, and our vision for the future as a single-source industry leader."
"I've been impressed with Aphena's increasing leadership in the pharmaceutical packaging industry in recent years," said Foster. "To me, this was a logical next step in my career, and I am eager to begin working with such a quality-driven team."
A senior-level regulatory/quality professional with more than 25 years of experience, Foster comes to Aphena from Catalent Pharma Solutions, where she served as vice president of quality. In that role, she was responsible for creating a global current Good Manufacturing Practices (cGMP) program and for training and developing connections within the industry and worldwide regulatory bodies to ensure continuous understanding and improvement of quality processes.
"We're so pleased to have Mary join the company. It is our intent to employ the industry's best and brightest, Mary certainly fits that category" said Aphena President and CEO Renard Jackson. "She shares our company's values, our focus on client expectations, and our vision for the future as a single-source industry leader."
"I've been impressed with Aphena's increasing leadership in the pharmaceutical packaging industry in recent years," said Foster. "To me, this was a logical next step in my career, and I am eager to begin working with such a quality-driven team."
Companies in this article
![“Another key [UDI] benefit, because we're calling that product by the same name across the healthcare supply chain… rich and robust data that we can access around supply consumption and utilization rates. One of the buzz terms we've heard during the COVID-19 crisis was what's my burn rate? How fast am I going through gowns, masks, gloves?” – Mike Schiller, Senior Director at AHRMM](https://img.healthcarepackaging.com/files/base/pmmi/all/image/2020/08/UDI.5f4d326e41d53.png?auto=format&fit=crop&h=146&w=340)
